U430医药(L11215)
动态评分： 0.00分
业绩表现
| 总收益 | 年化收益 | 标准差 | 夏普比率 | 最大回撤 | 最大收益 | |
| 成立以来 | 22.61% | 2.1% | 7.93% | 9.64% | -71.18% | 250.24% |
| 过去1年 | 23.29% | 5.33% | 10.31% | -16.44% | 61.8% | |
| 过去2年 | 14.77% | 7.13% | 9.83% | -32.04% | -33.47% | 72.31% |
| 过去3年 | 2.84% | 0.94% | 9.08% | -11.79% | -49.32% | 72.31% |
| 过去5年 | -37.94% | -9.1% | 8.84% | -50.99% | -71.18% | 43.39% |